Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Apr 13, 2022
Open Peer Review Period: Apr 13, 2022 - Jun 8, 2022
Date Accepted: Jul 25, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Newborn Skin Maturity Medical Device Validation for Gestational Age Prediction: Clinical Trial

Silveira Nogueira Reis Z, Romanelli RMdC, Guimarães RN, Gaspar JdS, Neves GS, do Vale MS, Nader PdJH, de Moura MDR, Vitral GLN, dos Reis MAA, Pereira MMM, Marques PF, Nader SS, Harff AL, Beleza LdO, de Castro MEC, Souza RG, Pappa GL, de Aguiar RAPL

Newborn Skin Maturity Medical Device Validation for Gestational Age Prediction: Clinical Trial

J Med Internet Res 2022;24(9):e38727

DOI: 10.2196/38727

PMID: 36069805

PMCID: 9494223

Newborn skin maturity medical device validation for gestational age prediction: a clinical trial

  • Zilma Silveira Nogueira Reis; 
  • Roberta Maia de Castro Romanelli; 
  • Rodney Nascimento Guimarães; 
  • Juliano de Souza Gaspar; 
  • Gabriela Silveira Neves; 
  • Marynea Silva do Vale; 
  • Paulo de Jesus H Nader; 
  • Martha David Rocha de Moura; 
  • Gabriela Luíza Nogueira Vitral; 
  • Marconi Augusto Aguiar dos Reis; 
  • Marcia Margarida Mendonça Pereira; 
  • Patrícia Franco Marques; 
  • Silvana Salgado Nader; 
  • Augusta Luize Harff; 
  • Ludmylla de Oliveira Beleza; 
  • Maria Eduarda Canellas de Castro; 
  • Rayner Guilherme Souza; 
  • Gisele Lobo Pappa; 
  • Regina Amélia Pessoa Lopes de Aguiar

ABSTRACT

Background:

The early access to prenatal care and high-cost technologies for pregnancy dating challenge the early neonatal risks assessment at birth in resource-constrained settings. To overcome the absence or low accuracy of postnatal gestational age, we developed a frugal innovation based on the photobiological properties of the newborn's skin and predictive models.

Objective:

This study aims to validate the photobiological model of skin maturity adjusted to the clinical data to promptly detect gestational age and determine its accuracy in detecting prematurity.

Methods:

A multicenter single-blinding and single-arm clinical trial intention-to-diagnosis evaluated the accuracy of a novel device to detect gestational age and preterm newborns. The first-trimester ultrasound (US), a second comparator US, and the last menstrual period (LMP) data from antenatal reports were the references for gestational age at birth. A portable multiband reflectance photometer assessed 781 newborns’ skin maturity and used machine learning models to predict gestational age, adjusted to birth weight and antenatal corticosteroid therapy exposure.

Results:

As the primary outcome, the predicted gestational by the new test had high agreement with the reference gestational age calculated with the intraclass correlation coefficient (0.970 [95%CI: 0.965, 0.974]) similar values to the comparator-US and better than the comparator-LMP gestational ages. As secondary outcomes, the new test achieved 97.7% (95%CI: 96.5%, 98.6%) agreement with the reference gestational age within one-week error. This value surpassed those of comparator-US (91.3% [95%CI: 89.2%, 93.1%]), and of comparator-LMP gestational ages (64.1% [60.7% to 67.5%]). Bland-Altman limits of the new test were -7.1 to 4.7 days. Prematurity discrimination with the novel device had the area under the receiver operating characteristic curve (AUROC) (0.998 [95%CI: 0.997, 1.000]), similar to comparator-US (0.996 [95% CI: 0.993, 0.999)]; and superior to comparator-LMP gestational ages (0.957 [95%CI:0.941, 0.974]). In newborns with absent or unreliable LMP (n=451), the intent-to-discriminate analysis showed correct classifications with the new test of 96.5% (95%CI: 94.3%, 98.0%), while with the comparator-LMP gestational age was 69.6% (95% CI: 65.3%, 73.7%).

Conclusions:

The assessment of the newborn's skin maturity adjusted by learning models promises accurate pregnancy dating at birth even without the antenatal ultrasound reference. Clinical Trial: WHO’s International Clinical Trial Platform - Brazilian Clinical Trials Registry RBR-3f5bm5.


 Citation

Please cite as:

Silveira Nogueira Reis Z, Romanelli RMdC, Guimarães RN, Gaspar JdS, Neves GS, do Vale MS, Nader PdJH, de Moura MDR, Vitral GLN, dos Reis MAA, Pereira MMM, Marques PF, Nader SS, Harff AL, Beleza LdO, de Castro MEC, Souza RG, Pappa GL, de Aguiar RAPL

Newborn Skin Maturity Medical Device Validation for Gestational Age Prediction: Clinical Trial

J Med Internet Res 2022;24(9):e38727

DOI: 10.2196/38727

PMID: 36069805

PMCID: 9494223

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.